Sean Dodge
Stock Analyst at BMO Capital
(2.07)
# 2,956
Out of 5,182 analysts
163
Total ratings
35.9%
Success rate
-3.89%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Maintains: Outperform | $52 → $60 | $54.83 | +9.43% | 2 | May 4, 2026 | |
| MEDP Medpace Holdings | Maintains: Market Perform | $460 → $400 | $424.00 | -5.66% | 2 | Apr 24, 2026 | |
| HCSG Healthcare Services Group | Maintains: Market Perform | $22 → $24 | $23.03 | +4.21% | 15 | Apr 23, 2026 | |
| HQY HealthEquity | Upgrades: Outperform | $85 → $105 | $84.84 | +23.76% | 14 | Apr 9, 2026 | |
| PHR Phreesia | Maintains: Outperform | $32 → $14 | $10.17 | +37.66% | 17 | Mar 31, 2026 | |
| ICLR ICON Public Limited Company | Upgrades: Outperform | $100 → $130 | $124.49 | +4.43% | 4 | Mar 26, 2026 | |
| AVAH Aveanna Healthcare Holdings | Maintains: Outperform | $11 → $10 | $6.74 | +48.37% | 2 | Mar 20, 2026 | |
| OMDA Omada Health | Maintains: Outperform | $27 → $18 | $14.82 | +21.46% | 2 | Mar 6, 2026 | |
| TDOC Teladoc Health | Maintains: Market Perform | $8 → $5 | $7.25 | -31.03% | 18 | Feb 26, 2026 | |
| MDLN Medline | Maintains: Outperform | $45 → $54 | $39.52 | +36.64% | 2 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $47 → $30 | $21.38 | +40.32% | 4 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Outperform | $24 | $15.78 | +52.09% | 12 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $120 | $99.57 | +20.52% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $4.18 | +67.46% | 10 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $260 | $178.71 | +45.49% | 7 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $9 | $6.31 | +42.63% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $300 | $166.34 | +80.35% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $8 | $7.70 | +3.90% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $30 | $23.06 | +30.10% | 3 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $55 | $25.98 | +111.70% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $7 → $6 | $1.52 | +294.74% | 10 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $88 | $54.23 | +61.35% | 7 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $7 → $6 | $6.44 | -6.83% | 11 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $25.83 | -45.80% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $2.92 | +242.47% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $185.94 | -82.25% | 1 | Sep 14, 2022 |
BrightSpring Health Services
May 4, 2026
Maintains: Outperform
Price Target: $52 → $60
Current: $54.83
Upside: +9.43%
Medpace Holdings
Apr 24, 2026
Maintains: Market Perform
Price Target: $460 → $400
Current: $424.00
Upside: -5.66%
Healthcare Services Group
Apr 23, 2026
Maintains: Market Perform
Price Target: $22 → $24
Current: $23.03
Upside: +4.21%
HealthEquity
Apr 9, 2026
Upgrades: Outperform
Price Target: $85 → $105
Current: $84.84
Upside: +23.76%
Phreesia
Mar 31, 2026
Maintains: Outperform
Price Target: $32 → $14
Current: $10.17
Upside: +37.66%
ICON Public Limited Company
Mar 26, 2026
Upgrades: Outperform
Price Target: $100 → $130
Current: $124.49
Upside: +4.43%
Aveanna Healthcare Holdings
Mar 20, 2026
Maintains: Outperform
Price Target: $11 → $10
Current: $6.74
Upside: +48.37%
Omada Health
Mar 6, 2026
Maintains: Outperform
Price Target: $27 → $18
Current: $14.82
Upside: +21.46%
Teladoc Health
Feb 26, 2026
Maintains: Market Perform
Price Target: $8 → $5
Current: $7.25
Upside: -31.03%
Medline
Feb 26, 2026
Maintains: Outperform
Price Target: $45 → $54
Current: $39.52
Upside: +36.64%
Feb 18, 2026
Maintains: Outperform
Price Target: $47 → $30
Current: $21.38
Upside: +40.32%
Jan 9, 2026
Reinstates: Outperform
Price Target: $24
Current: $15.78
Upside: +52.09%
Nov 13, 2025
Initiates: Market Perform
Price Target: $120
Current: $99.57
Upside: +20.52%
Nov 13, 2025
Initiates: Outperform
Price Target: $7
Current: $4.18
Upside: +67.46%
Nov 13, 2025
Initiates: Outperform
Price Target: $260
Current: $178.71
Upside: +45.49%
Nov 13, 2025
Initiates: Market Perform
Price Target: $9
Current: $6.31
Upside: +42.63%
Nov 13, 2025
Initiates: Market Perform
Price Target: $300
Current: $166.34
Upside: +80.35%
Nov 13, 2025
Initiates: Outperform
Price Target: $8
Current: $7.70
Upside: +3.90%
Nov 13, 2025
Initiates: Outperform
Price Target: $30
Current: $23.06
Upside: +30.10%
Nov 13, 2025
Initiates: Market Perform
Price Target: $55
Current: $25.98
Upside: +111.70%
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $1.52
Upside: +294.74%
Feb 26, 2025
Maintains: Outperform
Price Target: $75 → $88
Current: $54.23
Upside: +61.35%
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $6.44
Upside: -6.83%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $25.83
Upside: -45.80%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $2.92
Upside: +242.47%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $185.94
Upside: -82.25%